BIOSECURE Act

Chairman John Moolenaar (R-MI) of the House Select Committee on the Chinese Communist Party joined Ranking Member Raja Krishnamoorthi (D-IL), and Rep. Brad Wenstrup (R-OH) to introduce the bipartisan BIOSECURE Act, a bill to ensure American patient data and taxpayer dollars do not fall into the hands of foreign adversaries' biotechnology companies of concern by prohibiting Federal contracting with these companies. This legislation builds on earlier efforts in the 118th Congress.
The Chinese Communist Party's (CCP) national security laws require all Chinese firms to share any requested data with the CCP, including biotechnology companies that collect, test, and store American genomic data. Beijing Genomics Institute (BGI), a company in the People's Republic of China (PRC), has collected DNA from millions around the world and used that data without consent on genomic projects conducted by the Chinese military. Chinese company WuXi AppTec has sponsored events with China's military, reportedly stolen U.S. intellectual property, and jointly operated genetic collection sites with China's military. Chinese biotechnology companies also have alarming ties to the ongoing genocide of Uyghurs in Xinjiang, China.
Why BIOSECURE Matters Now:
- WuXi AppTec makes over 60% of their revenue from the U.S. market, meaning U.S. consumers are directly facilitating the success of a company that poses a risk to our national security.
- BGI operates over 100 genetic collection laboratories in over 20 countries, infrastructure that the U.S.-China Economic and Security Review Commission declared was providing “genetic data to serve PRC ambitions to dominate biotech.”
- BGI used a pre-natal test to harvest the genetic data of over 8 million pregnant women in Europe, without notifying them their data was going to the PRC. This data would later be used to conduct research with the People's Liberation Army.
The text of BIOSECURE Act can be found HERE.
Original co-sponsors include: Neal Dunn (R-FL), Anna Eshoo (D-CA), Elise Stefanik (R-NY), Seth Moulton (D-MA), and Don Davis (D-NC).